AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 46 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $683,000 | -35.8% | 257,613 | +241.1% | 0.09% | -42.0% |
| Q1 2018 | $1,064,000 | +19.8% | 75,535 | 0.0% | 0.16% | +55.8% |
| Q4 2017 | $888,000 | -17.2% | 75,535 | 0.0% | 0.10% | -32.0% |
| Q3 2017 | $1,072,000 | +22.7% | 75,535 | +21.7% | 0.15% | +3.4% |
| Q2 2017 | $874,000 | -50.9% | 62,085 | -67.3% | 0.15% | -66.3% |
| Q2 2014 | $1,780,000 | -26.4% | 190,000 | 0.0% | 0.44% | -20.5% |
| Q1 2014 | $2,419,000 | – | 190,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 179,162 | $2,523,000 | 1.80% |
| Baker Brothers Advisors | 10,934,154 | $153,953,000 | 1.30% |
| Ghost Tree Capital, LLC | 400,000 | $5,632,000 | 1.14% |
| Boxer Capital, LLC | 747,500 | $10,525,000 | 1.12% |
| DAFNA Capital Management LLC | 107,928 | $1,520,000 | 0.74% |
| UNIVERSITY OF NOTRE DAME DU LAC | 137,868 | $1,941,000 | 0.36% |
| Eversept Partners, LP | 31,987 | $450,377 | 0.21% |
| DLD Asset Management, LP | 147,900 | $2,078,000 | 0.19% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,535 | $1,064,000 | 0.16% |
| Stonepine Capital Management, LLC | 20,374 | $287,000 | 0.15% |